Joint Annual Collaborators' Meeting 2024 - Agenda
THURSDAY 16 MAY 2024
| 12:00 - 14:00 | Registration and buffet lunch | |
| 14:00 - 14:10 | Introduction and welcome | Jane Armitage (CTSU, Oxford) |
| 14:10 - 14:40 | REPRIEVE - pitavastatin to prevent cardiovascular disease in patients with HIV | Steven Grinspoon (Harvard, Boston) |
| 14:40 - 15:00 | ASCEND PLUS update - oral semaglutide to reduce complications of diabetes | Rohan Wijesurendra (CTSU, Oxford) |
| 15:00 - 15:20 | ASCEND EYE - The effects of asprin and omega-3 fatty acids on common eye diseases | Emily Sammons (CTSU, Oxford) |
| 15:20 - 16:00 | Tea and coffee | |
| 16:00 - 16:30 | Trials in cardiogenic shock and out-of-hospital cardiac arrest | Christian Hassanger (Rigshospitalet, Copenhagen) |
| 16:30 - 16:50 | ORION-4 trial update - inclisiran to prevent cardiovascular disease | Louise Bowman (CTSU, Oxford) |
| 16:50 - 17:20 | Extending the age range for routine breast cancer screening: the AgeX Trial | Toral Gathani (Cancer Epidemiology Unit, Oxford) |
| 19:00 - 20:00 | Drinks reception | |
| 20:00 | Dinner |
FRIDAY 17 MAY 2024
| 07:00 - 08:45 | Registration and breakfast | |
09:00 - 09:05 |
Introduction and welcome |
Rory Collins |
| 09:05 - 09:20 | Too frail for flozins? |
Kaitlin Mayne |
| 09:20 - 09:30 |
Long-term follow up of the EMPA-KIDNEY trial |
Nikita Agrawal (CTSU, Oxford) |
| 09:30 - 10:00 | EASi-KIDNEY update: aldosterone synthase inhibition for patients with chronic kidney disease | Parminder Judge (CTSU, Oxford) |
| 10:00 - 10:30 | Decentralised trials in the UK and beyond | Isla Mackenzie (MEMO Research, Dundee) |
| 10:30 - 11:00 | Tea and coffee | |
| 11:00 - 11:30 | Population-based studies for cardiovascular benefit in Denmark: DANCANVAS and beyond | Axel Diederichsen (Odense University Hospital, Denmark) |
| 11:30 - 12:00 | On the path to cure chronic kidney disease | Christoph Wanner (Nephrology, Wurzburg) |
| 12:00 - 13:00 | Lunch |